2Schwarzer U. The prevalence of Peyronie's disease: resuits of a large survey[J]. BJU Int,2001,88(7) :727.
3Mulhall JP. Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screeningEJ]. J Urol, 2004,171 : 2350.
4Gholami SS. Peyronie' s disease: a review[J]. J Urol, 2002,169 : 1234.
5Brant WO, Dean RC, Lue TF. Treatment of Peyronie's disease with oral pentoxifylline [J]. Nature Clin Pract Urol,2006,3:111.
6Bjekic MD, Vlajinae HD, Sipetic SB, et al.. Risk factors for Peyronie's disease: a case-control study[J]. BJU Int, 2006,97(3) : 570.
7Di Stasi SM, Giannantoni A, Stephen RL, et al. A prospective, randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease[J]. J Urol, 2004,171 (4) : 1605.
8Altar H, Syed H, Abbasi TB, et al. Nesbit procedure for disabling Peyronier's curvature: a median follow - up of 84 months[J]. Urology,2003,61(5) : 1001.
9Kadioglu A, Sanli O, Akman T, et al. Graft materials of Peyronier's disease surgery:a comprehensive review[J]. J Sex Med,2007,4(3) ,581.
10Chao ST,Joyce M J,Suh JH. Treatment of heterotopic ossification[J].{H}ORTHOPEDICS,2007,(06):457-464.
